Sphingosine kinase 2 (SPHK2) inhibition as a therapeutic strategy for adrenocortical carcinoma (ACC) (2026)
Attributed to:
Deciphering mechanisms of disease associated with Sphingosine-1-phosphate lyase deficiency
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1530/endoabs.117.oc2.4
Publication URI: http://dx.doi.org/10.1530/endoabs.117.oc2.4
Type: Journal Article/Review
Parent Publication: Endocrine Abstracts